西南医科大学学报2026，Vol.49Issue(1)：45-49,5.DOI:10.3969/j.issn.2096-3351.2026.01.009
代谢相关脂肪性肝病与肌肉减少症的研究进展
Research Progress on Metabolic Fatty Liver Disease and Sarcopenia
ZHANG Lei 1LIU Lidan 2TANG Haoqing3
作者信息
- 1. Department of Internal Medicine,Luoyang New Milestone Hospital,Luoyang 471003,China
- 2. Department of Internal Medicine,The 96606th Troop Hospital of the People's Liberation Army,Luoyang 471003,China
- 3. Department of Internal Orthopedics,The Sixth People's Hospital of Luoyang,Luoyang 471003,China
- 折叠
摘要
Abstract
The prevalence of metabolic associated fatty liver disease(MAFLD)has increased substantially in recent years due to the global obesity epidemic.Sarcopenia(SP)exacerbates MAFLD through reduced physical capacity and altered myokine signaling.These two conditions interact synergistically,amplifying disease progression.A comprehensive understanding of the two diseases com-plex,particularly in the context of their coexistence,is therefore imperative.This comprehensive clinical update review examines the pathobiological interplay between MAFLD and sarcopenia,discusses their collective clinical impact,provides recommendations for the assessment and diagnosis of sarcopenia,and proposes evidence-based therapeutic strategies to improve patient quality of life.关键词
代谢相关脂肪性肝病/肌肉肌少症Key words
Metabolic associated fatty liver disease/Sarcopenia分类
医药卫生引用本文复制引用
ZHANG Lei,LIU Lidan,TANG Haoqing..代谢相关脂肪性肝病与肌肉减少症的研究进展[J].西南医科大学学报,2026,49(1):45-49,5.
